Company: REVB
Filing Date: 2025-04-04
Form Type: DRS
Source: 0001213900-25-029022
Chunk: 78

Company: REVELATION BIOSCIENCES, INC.
Filing Date: 2025-04-04
Form: DRS
Chunk 78
---
 tangible book value per share of common stock immediately after this offering. Our net tangible book value is the amount of our total tangible assets less our total liabilities. We had a net tangible book value as of December 31, 2024 of $4,708,382, or $9.01share of common stock. Pro forma as adjusted net tangible book value is our pro forma net tangible book value, plus the effect of the sale of our securities in this offering at the public offering price of $[•] per share of common stock and accompanying Common Stock Warrants and after deducting the Placement Agent fees and commissions and other estimated offering expenses payable by us. Our pro forma as adjusted net tangible book value as of December 31, 2024 would have been approximately $, or $per share. This amount represents an immediate decrease in pro forma as adjusted net tangible book value of approximately $per share to our existing stockholders, and an immediate dilution of $per share to new investors participating in this offering. Dilution per share to new investors is determined by subtracting pro forma as adjusted net tangible book value per share after this offering from the public offering price per share paid by new investors. The following table illustrates this per share dilution:

| Assumed public offering price per share (attributing no value to the warrants)               |     | $ |      |
| Net tangible book value per share as of December 31, 2024                                    |     | $ | 9.01 |
| Decrease in pro forma as adjusted net tangible book value per share after this offering      |     | $ |      |
| Pro forma as adjusted net tangible book value per share after giving effect of this offering |     | $ |      |
| Dilution in pro forma as adjusted net tangible book value per share to new investors         |     | $ |      |

Each $1.00 increase (decrease) in the public offering price of $per share and accompanying Common Stock Warrants would increase (decrease) the pro forma as adjusted net tangible book value per share by $, and the dilution per share to new investors in this offering by $, assuming the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting the Placement Agent fees and commissions and estimated offering expenses payable by us. Each increase of 1,000,000 in the number of shares of common stock and accompanying Common Stock Warrants sold in this offering would